N2 PHARMACEUTICALS LTD Company Profile, Contacts & Intelligence

N2 PHARMACEUTICALS LTD Overview

- Medical Research Scotland PhD studentship award winners - 2020 - SMART Scotland Grant winners - 2018 - Animal Health Investment Europe showcase finalists - London 2018 - Informa Disruptors & innovators report 2018 Top 20 Animal Health start-ups N2 Pharmaceuticals has developed and patented a proprietary method to extract bioactive peptides (N2-01) from Mytilus edulis (Blue mussels). N2-01 has already been used in 25,000+ farm and companion animals and is proven to reduce mortality in multiple conditions associated with endothelial dysfunction, including Porcine circovirus type 2. In studies to date, N2-01 has been shown to significantly reduce endothelial dysfunction and vascular leakage in human endothelial cells. Based in Edinburgh, N2 Pharmaceuticals intend to repurpose N2-01 from animal health applications to treat a number of acute human diseases associated with endothelial dysfunction.

Headquarters

Edinburgh, City of, United Kingdom

Website

n2pharma.co.uk

Industry

Biotechnology

Founded

2013

N2 PHARMACEUTICALS LTD Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

N2 PHARMACEUTICALS LTD People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Compare Similar Companies to N2 PHARMACEUTICALS LTD

Explore companies in related markets and compare their industry and employee estimates.